NYSE · traded in Congress
Transdigm Group TDG
$1,196.97 +7.78 (+0.65%) Nov 6, 2026
Market value$66.2B
P/E ratio-
Analyst target$1,402.50
52-week range-
Avg volume472,615
Dividend yield-
Chart
Earnings
Transdigm Group reports Tuesday, November 10, before the open.
Analyst ratings
- 13 buy
- 11 hold
- 1 sell
Low target$1,100.00
Average target$1,410.06
High target$1,745.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $2,741M | $1,628M | $539M | 19.7% | |
| $2,544M | $1,511M | $535M | 21.0% | |
| $2,285M | $1,352M | $445M | 19.5% | |
| $2,438M | $1,470M | $610M | 25.0% |
Congress trades in TDG
Members of Congress disclosed 14 transactions in TDG in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 08/25/2026 | April McClain Delaney MD06 | Sale | $100,001 - $250,000 | 9/9/2026 filing |
| 07/28/2026 | April McClain Delaney MD06 | Purchase | $1,001 - $15,000 | 8/3/2026 filing |
| 05/22/2026 | April McClain Delaney MD06 | Purchase | $1,001 - $15,000 | 6/5/2026 filing |
| 05/21/2026 | April McClain Delaney MD06 | Purchase | $1,001 - $15,000 | 6/5/2026 filing |
| 05/13/2026 | April McClain Delaney MD06 | Purchase | $1,001 - $15,000 | 6/5/2026 filing |
| 05/08/2026 | April McClain Delaney MD06 | Purchase | $1,001 - $15,000 | 6/5/2026 filing |
| 05/07/2026 | April McClain Delaney MD06 | Purchase | $1,001 - $15,000 | 6/5/2026 filing |
| 04/29/2026 | April McClain Delaney MD06 | Purchase | $1,001 - $15,000 | 5/6/2026 filing |
| 04/20/2026 | April McClain Delaney MD06 | Purchase | $1,001 - $15,000 | 5/6/2026 filing |
| 04/17/2026 | April McClain Delaney MD06 | Purchase | $1,001 - $15,000 | 5/6/2026 filing |
| 04/16/2026 | April McClain Delaney MD06 | Purchase | $15,001 - $50,000 | 5/6/2026 filing |
| 04/15/2026 | April McClain Delaney MD06 | Purchase | $1,001 - $15,000 | 5/6/2026 filing |
| 03/25/2026 | Gilbert Cisneros CA31 | Partial sale | $1,001 - $15,000 | 4/7/2026 filing |
| 03/16/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 4/7/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
